Alnylam Pharmaceuticals Inc

NASDAQ:ALNY   3:59:53 PM EDT
209.48
-1.28 (-0.61%)
Debt Financing / Related, Equity Financing / Related

Alnylam Announces Pricing Of Offering Of $900 Million Convertible Senior Notes

Published: 09/13/2022 10:12 GMT
Alnylam Pharmaceuticals Inc (ALNY) - Alnylam Announces Pricing of Offering of $900 Million Convertible Senior Notes.
Alnylam Pharmaceuticals - Pricing of Private Offering of $900 Million Aggregate Principal Amount of 1.00% Convertible Senior Notes Due 2027.
Alnylam - Conversion Rate is 3.49 Shares of Common Stock per $1,000 Principal Amount of Notes, Represents Conversion Price of About $286.20per Share.